|
⚲
|
| Keyboard |
| Tyler Joseph E
✚
|
|
|---|---|
| CIK # | 0001212744 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001212744] | |
| 4 | [0001212744] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Tyler Joseph E | |
| Spyre Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Spyre Therapeutics Inc AGLE
Employee Stock Option (right to buy) · derivative
|
2017-08-22 | Grant | 25,000 | $0.00 | |
|
Spyre Therapeutics Inc AGLE
Employee Stock Option (right to buy) · derivative
|
2017-03-20 | Grant | 39,000 | $0.00 | |
|
Spyre Therapeutics Inc AGLE
Employee Stock Option (right to buy) · derivative
|
2016-05-17 | Grant | 33,000 | $0.00 | |
|
Spyre Therapeutics Inc AGLE
Common Stock
|
2016-04-12 | Conversion | 31,260 | $0.00 | |
|
Spyre Therapeutics Inc AGLE
Series A Preferred Stock · derivative
|
2016-04-12 | Conversion | 22,857 | $0.00 | |
|
Spyre Therapeutics Inc AGLE
Series B Preferred Stock · derivative
|
2016-04-12 | Conversion | 8,403 | $0.00 |